Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
Level 3 - non-randomized controlled study
Observational cohort study with longitudinal cognitive follow-up
PubMed 38667631 · doi:10.1093/brain/awae116
What was done
Researchers evaluated 601 participants (537 cognitively unimpaired, 48 with mild cognitive impairment, and 16 with dementia) from two Wisconsin cohorts who underwent 11C-PiB amyloid PET, 18F-MK-6240 tau PET, and neuropsychological testing. Using amyloid PET and sampled iterative local approximation, they estimated the age of amyloid positivity onset (A+ threshold > 1.16 DVR / 17.1 centiloids) and duration of amyloid exposure. Whole-brain voxel-wise and regional tau PET uptake were mapped across amyloid chronicity. Mixed effects models assessed the interaction between A+ duration and entorhinal tau burden on longitudinal cognitive decline among 472 initially unimpaired participants.
What was found
Voxel-wise analyses showed that measurable tau spread expanded from early to late neurofibrillary tangle regions with each decade of amyloid positivity. Entorhinal cortex tau burden became detectable on average within 10 years of amyloid positivity onset and was the most sensitive region to early amyloid pathology and clinical impairment. In 472 initially unimpaired participants, mixed effects models showed significant linear and non-linear interactions between amyloid duration and entorhinal tau on cognitive decline, demonstrating a synergistic acceleration of impairment. Specific numeric effect sizes and confidence intervals were not reported in the abstract.
Why it matters
Anchoring Alzheimer's disease pathology to the estimated onset and duration of amyloid positivity provides a temporal framework linking amyloid chronicity to tau spread and cognitive deterioration. This timeline may help stratify prognosis and identify optimal therapeutic windows for interventions.
Limits
The study sample was heavily skewed toward cognitively unimpaired individuals (89%), with very few dementia cases (n = 16). Longitudinal disease progression of tau was inferred primarily from cross-sectional tau PET rather than serial tau scans. Amyloid duration relies on modeled estimates of onset age rather than direct long-term observation from inception.